INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
批准号:
6603831
负责人:
Mitchell P. Fink
金额:
$32.65万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 2004-06-30
中文摘要
描述:(改编自申请人的摘要)。的长期目标是
这一应用是为了阐明负责的基本机制
急性组织缺氧相关状态下的肠屏障功能障碍
和/或炎症。一个统一的假设是,细胞内的错乱
能量代谢引起或促成上皮屏障的改变
在危重疾病中发挥作用。目的研究细胞因子介导的阻遏作用。
缺氧诱导因子-1(HIF-1)依赖的适应性上皮细胞对
脓毒症期间的缺氧。HIF-1是一种转录因子,调节
与适应性细胞反应相关的一些基因的表达
缺氧。在初步研究中,他们证明了HIF-1DNA结合
当培养的肝细胞和肠细胞孵育时,活性增加
在常氧条件下应用干扰素-γ和肿瘤坏死因子的混合物。然而,这些细胞因子
未能诱导依赖于HIF-1的荧光素酶报告基因的表达。
最近,这些细胞因子抑制HIF-1依赖的报告活性
缺氧。申请人假设(1)HIF-1DNA结合活性将
败血症动物肝脏和肠道粘膜的增加;(2)适应性
细胞或组织对低氧的反应会受到损害
暴露在促炎环境中(如败血症时);
干扰素和肿瘤坏死因子启动的信号转导抑制HIF-1诱导的基因表达
阻断CBP/p300在低氧诱导下的募集表达
推动者。目标二是评估一种潜在的方式,即
胞内游离钙离子浓度[Ca~(2+)]_i升高
肠上皮细胞旁通透性。他们之前的研究表明
ATP耗竭引起的上皮高通透性依赖于
由此产生的[Ca~(2+)]i升高的机制(S)
促进高渗透性是未知的。在AIM II中,他们将进行实验
为了检验[Ca~(2+)]i升高会导致A细胞活化的假设
钙依赖酶,肌球蛋白轻链激酶(MLCK),从而
增加20 kDa细胞骨架蛋白肌球蛋白LIGH的磷酸化
链(MLC20),导致细胞骨架收缩和上皮
在此基础上的高渗透性。目的三是调查
细胞因子、缺氧或对极化的代谢抑制
复合碳水化合物和其他亲水性物质的基侧到顶端的运输
肠道上皮中的化合物。这些研究是由以下因素推动的
他们获得的初步数据表明,各种各样的
化合物,包括右旋糖苷和各种阴离子染料,被输送到
大鼠结肠粘膜通过一种过程向浆膜到粘膜的方向
显然是能源依赖型的。基于这些发现,我们假设
脓毒症(或其他形式的急性疾病)的屏障功能受损可能
不仅反映了根尖到基底外侧被动渗透的增加
但也减少了相反方向的主动抽水(扫气)
方向。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract). The long- term goal of
this application is to elucidate the fundamental mechanisms responsible for
intestinal barrier dysfunction in states associated with acute tissue hypoxia
and/or inflammation. One unifying hypothesis is that derangements in cellular
energy metabolism cause or contribute to alterations in epithelial barrier
function in critical illness. Aim I is to study cytokine mediated repression of
hypoxia-inducible factor-1 (HIF-1)-dependent adaptive epithelial responses to
hypoxia during sepsis. HIF-1 is a transcription factor that regulates the
expression of a number of genes associated with adaptive cellular responses to
hypoxia. In preliminary studies, they demonstrated that HIF-1 DNA-binding
activity is increased when cultured hepatocytes and enterocytes are incubated
with a mixture of IFN-gamma and TNF under normoxia. However, these cytokines
fail to induce the expression of a HIF-1-dependent luciferase reporter gene.
More recently, these cytokines inhibit HIF-1-dependent reporter activity during
hypoxia. The applicants hypothesize that (1) HIF-1 DNA-binding activity will
increase in the liver and intestinal mucosa of septic animals; (2) adaptive
cellular responses to hypoxia will be impaired in cells or tissues that have
been exposed to a pro-inflammatory milieu (such as occurs in sepsis); (3)
signaling initiated by IFN-gamma and TNF suppresses HIF-1-induced gene
expression by blocking the recruitment of CBP/p300 to hypoxia-inducible
promoters. Aim II is to evaluate one potential way that an increase in
cytosolic ionized calcium concentration, [Ca2+] i, could act to increase
intestinal epithelial paracellular permeability. They previously showed that
epithelial hyperpermeability caused by ATP depletion is dependent upon the
resultant increase in [Ca2+] i. The mechanism(s) whereby increases in [Ca2+] i
promote hyperpermeability are unknown. In Aim II they will conduct experiments
to test the hypothesis that elevation of [Ca2+] i leads to activation of a
calcium-dependent enzyme, myosin light chain kinase (MLCK), and thereby
increases phosphorylation of the 20-kDa cytoskeletal protein, myosin light
chain (MLC20), resulting in cytoskeletal contraction and epithelial
hyperpermeability on that basis. Aim III is to investigate the effect of
cytokines, hypoxia, or metabolic inhibition on the polarized
basolateral-to-apical transport of complex carbohydrates and other hydrophilic
compounds across the intestinal epithelium. These studies are prompted by
preliminary data they have obtained, which indicate that a wide variety of
compounds, including dextrans and various anionic dyes, are transported across
rat colonic mucosa in the serosa-to-mucosa direction via a process that
apparently is energy-dependent. Based on these findings, we hypothesize that
that impaired barrier function in sepsis (or other forms of acute illness) may
not just reflect increased passive permeation in the apical-to basolateral
direction, but also decreased active pumping (scavenging) in the opposite
direction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR BASIS FOR EPITHELIAL BARRIER DYSFUNCTION/PROJECT 2
-
批准号:6829217
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2004
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6765286
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6911508
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6669337
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466035
-
项目类别:
-
资助金额:$9.74万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2684840
-
项目类别:
-
资助金额:$29.47万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2178852
-
项目类别:
-
资助金额:$22.23万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466038
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466034
-
项目类别:
-
资助金额:$9.39万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2178851
-
项目类别:
-
资助金额:$21.36万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:6197428
-
项目类别:
-
资助金额:$32.52万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466037
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2900634
-
项目类别:
-
资助金额:$28.43万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:6785026
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:6519241
-
项目类别:
-
资助金额:$32.76万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2392016
-
项目类别:
-
资助金额:$29.05万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:6873675
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:7089011
-
项目类别:
-
资助金额:$33.86万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466039
-
项目类别:
-
资助金额:$6.58万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466036
-
项目类别:
-
资助金额:$9.71万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
海外基金